Be the first to like. Like Unlike

Quick Read

The U.S. government’s leading medical research agency is quietly extending and reviving research that relies on human fetal tissue, even as President Donald Trump’s administration ponders the future of the controversial work in a far-reaching review

Quick Read

Tired of regulatory confusion and a lack of funding, some US researchers are taking their gene-edited livestock abroad

Quick Read

In a recent documentary, the geneticist doubled down on comments he made a decade ago, then apologized for, regarding race, genetics and intelligence

Quick Read

The US Department of Health and Human Services is vigorously contesting a report, published by The Washington Post, that it has decided to cancel a $2-million-a-year contract that funds work using human fetal tissue to develop mice with humanlike immune systems for testing drugs against HIV

Quick Read

A paper on overdose-reversal drugs reached a conclusion no one liked. The pushback raised questions about sexism and scientific methods

Quick Read

Statues: An Editorial Response

September 19, 2017

Philip Campbell, Editor-in-Chief of Nature responds to the widespread criticisms to an editorial warning about the risks of “removing statues or altering the names of awards or streets that honor researchers who committed atrocious acts in the name of science.”

Quick Read

Major investment in regenerative medicine enters its last stage — and the money might run out before treatments are ready

Quick Read